The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Benefit of MGMT methylation in glioblastoma in relation to hTERT promoter mutation.
 
HuyTram N Nguyen
No Relationships to Disclose
 
Tie Li
No Relationships to Disclose
 
Amy Lie
No Relationships to Disclose
 
Byram H Ozer
No Relationships to Disclose
 
Reshmi Chowdhury
No Relationships to Disclose
 
Fei Liu
No Relationships to Disclose
 
Bowen Wei
Employment - Boehringer Ingelheim (I)
 
He-jing Wang
No Relationships to Disclose
 
Robert M. Elashoff
No Relationships to Disclose
 
Linda M. Liau
Research Funding - Northwest Biotherapeutics (Inst)
 
William H. Yong
Stock and Other Ownership Interests - Johnson & Johnson (I); Procter & Gamble (I)
Research Funding - Amgen
 
Benjamin M. Ellingson
No Relationships to Disclose
 
Phioanh Leia Nghiemphu
Consulting or Advisory Role - Novocure
Research Funding - Genentech/Roche; GlaxoSmithKline
 
Timothy Francis Cloughesy
Consulting or Advisory Role - Abbvie; Agios; Amgen; Celgene; Celldex; cortice; CytRx Corporation; Lpath; Nektar; NewGen Therapeutics; Novartis; Novocure; Oxigene; proximagen; Roche/Genentech; Stemcycle; Tocagen; Upsher-Smith; VBL Therapeutics; wellcome trust
 
Albert Lai
Consulting or Advisory Role - Roche/Genentech
Research Funding - Millennium; Roche/Genentech